The Medical City
About The Medical City
Professional Services Inc. operating as The Medical City is a health institution in the Philippines which maintains a network of hospitals and clinics in the Philippines. The TMC also maintains the Guam Regional Medical City in Guam and a network of clinics in the Gulf states.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Allergan
2
Philippine Neurological Association
2
Apellis Pharmaceuticals, Inc.
1
Asan Medical Center
1
Bioven Europe
1
Boehringer Ingelheim
1
Clearside Biomedical, Inc.
1
Corbridge Group Philippines, Inc.
1
Fresenius Kabi
1
GenVivo, Inc.
1
Clinical Trials at The Medical City
During the past decade, The Medical City conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 7 clinical trials were completed, i.e. on
average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
2006-07-01
2012-09-01
Completed
208
The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney Disease
2009-11-01
2012-12-01
Unknown status
1,508
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
2009-06-01
2016-12-01
Unknown status
1,600
Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)
2010-07-01
2018-07-31
Unknown status
360
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
2011-02-01
2013-10-01
Completed
508
Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
2011-11-01
2013-01-01
Completed
345
Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia
2011-12-01
2012-12-01
Unknown status
56
Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients
2015-05-01
2019-09-06
Terminated
106
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Medical City" #1 sponsor was "Pfizer" with 3 trials, followed by "Allergan" with 2 trials
sponsored, "Philippine Neurological Association" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored and "Asan Medical Center"
with 1 trials sponsored. Other sponsors include 14 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Medical City"
#1 collaborator was "Alfasigma S.p.A." with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Baguio General Hospital and Medical Center, Philippines" with 1 trials as a collaborator, "Chong Hua Hospital, Philippines" with 1 trials as a collaborator and "East Avenue Medical Center, Philippines" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at The Medical City
According to Clinical.Site data, the most researched conditions in "The Medical City" are
"Covid19" (2 trials), "Hepatocellular Carcinoma" (2 trials), "Adnexal Mass" (1 trials), "Adult Soft Tissue Sarcoma" (1 trials) and "Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "The Medical City" in a lesser frequency.
Clinical Trials Intervention Types at The Medical City
Most popular intervention types in "The Medical City" are "Drug" (20 trials), "Device" (5 trials), "Biological" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "2.0 mg DE-122 Injectable Solution + Lucentis" (1 trials) and "4.0 mg DE-122 Injectable Solution + Lucentis" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Medical City
The vast majority of trials in "The Medical City" are
26 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at The Medical City
Currently, there are NaN active trials in "The Medical City".
undefined are not yet recruiting,
8 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in The Medical City,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in The Medical City, 3 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".